Merck and AstraZeneca Present Final Results of Key Secondary Overall Survival Endpoint From Phase 3 PROpel Trial at 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium | Business Wire
Full article: Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors
LYNPARZA® (olaparib) First-Line Maintenance Therapy Nearly Doubled the Time Without Disease Progression or Death in Phase 3 POL
ex99-1_005.jpg
Nejmoa 2206038 - NEJM - ####### T h e n e w e n g l a n d j o u r n a l o f m e d i c i n e n engl j - Studocu
Upper Gastrointestinal Bleeding Due to a Peptic Ulcer
Dr. Andrew Hendifar (@DrHendifar) / Twitter
Cancers | Free Full-Text | Clinical Candidates Targeting the ATR–CHK1–WEE1 Axis in Cancer
NEJM Journal Watch - Postitused | Facebook
PDF) Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening
POLO Trial - The ASCO Post
Albumin Replacement in Patients with Severe Sepsis or Septic Shock
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
Periodici elettronici - Accesso in trial a NEJM sul sito dell'editore fino al 14 giugno 2021 - Centro Servizi Bibliotecari
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
Update: What is new in targeted therapy for pancreatic cancer? - YouTube
Acute Lower Gastrointestinal Bleeding
Dear Oncology Fellows: We Must All Stand Up For Patients
Asco 2019 – Polo reveals an overall survival hole | Evaluate
NEJM Journal Watch - Home | Facebook
Folfirinox for Locally Advanced Pancreatic Adenocarcinoma. Results of an Ageo Multicentric Prospective Study
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
ex99-2_043.jpg
GI SLIDE DECK 2019 Selected abstracts from: - ppt download
Asco 2019 – Polo reveals an overall survival hole | Evaluate
